CytRx Acquires Innovive Pharmaceuticals
Los Angeles-based CytRx said today that it is in a definitive agreement to acquire Innovive Pharmaceuticals, Inc. Innovive is a biopharmaceuticals company developing oncology drugs. CytRx said it would pay $21.3M for Innovive, in addition to assuming the firm's liabilities. Innovive has four clinical stage oncology drug candidates in various stages of development.
posted on Monday, June 9, 2008
Related companies:
CytRx
Related stories:
> CytRx Names New CFO
> CytRx Sells Assets To Orphazyme
> Elevation Pharmaceuticals Pulls In $17M, Names Execs
> Allergan Buys MAP Pharmaceuticals
> Valeant Pharmaceuticals Sells Argentina Ops
socalTECH.com Home